Notes
Earnings Summary & Key Updates
🔸 Monster Beverage ( $MNST) Q4 EPS: $0.38 (vs. est. $0.40); Revenue up 4.7% YoY to $1.81B (vs. est. $1.8B). Gross profit margin improved to 55.5% (Non-GAAP). Operating income up 7.9% to $517.9M (Non-GAAP).
🔸 Tesla ( $TSLA) applied for a permit in California linked to chauffeur services, a step toward regulatory approval for its planned robotaxi service.
🔸 Array Technologies ( $ARRY) – Q4 adj. EPS: $0.16 (vs. est. $0.17), adj. EBITDA: $45.2M (vs. est. $47.6M), revenue: $275.2M (vs. est. $268.5M), gross margin: 28.5%. Q1 revenue guidance: $260M-$270M (vs. est. $292.17M), FY revenue: $1.05B-$1.15B (vs. est. $1.127B).
🔸 Bloom Energy ( $BE) – Q4 adj. EPS: $0.43 (vs. est. $0.30), revenue: $572.4M (vs. est. $508.28M), gross margin: 38.3%, op. margin: 18.3%. FY revenue guidance: $1.65B-$1.85B (vs. est. $1.671B), adj. op. income: $135M-$165M (vs. est. $126.44M).
🔸 EOG Resources ( $EOG) – Q4 adj. EPS: $2.74 (vs. est. $2.57), revenue: $5.59B (vs. est. $5.95B). Oil & gas volumes and costs outperformed guidance. Announced $6.2B 2025 capital plan to grow oil production 3% and total production 6%. Entered a strategic agreement with Bapco Energies in Bahrain.
🔸 Sunrun ( $RUN) – Q4 revenue: $518.5M (vs. est. $537.9M). Installed 392 MWh of storage, up 78% YoY, exceeding guidance. Storage attachment rate: 62%. Q1 cash generation expected at $40M-$50M.
🔸 Talen Energy ( $TLN) – FY adj. EBITDA: $770M, adj. free cash flow: $283M, exceeding 2024 guidance midpoints. Reaffirmed 2025 guidance; 2026 outlook unchanged.
🔸 Tidewater ( $TDW) – Q4 revenue: $345.1M (vs. est. $340.1M), adj. EBITDA: $138.4M (in line with estimates). FY revenue guidance: $1.32B-$1.38B (vs. est. $1.44B), gross margin: 48%-50% (vs. est. 50.1%).
🔸 CubeSmart ( $CUBE) – Q4 AFFO/share: $0.68 (in line), adj. EPS: $0.45 (vs. est. $0.46), revenue: $231.4M (vs. est. $266.4M). FY AFFO/share guidance: $2.50-$2.59 (vs. est. $2.68), EPS: $1.40-$1.49 (vs. est. $1.76).
🔸 Green Dot ( $GDOT) – Q4 EPS: $0.40 (vs. est. $0.35), revenue: $455M (vs. est. $421.9M). FY25 EPS guidance: $1.05-$1.20 (vs. est. $1.50), adj. EBITDA: $145M-$155M. Expects embedded finance and money movement to drive 2025 growth.
🔸 Redfin ( $RDFN) – Q4 EPS loss: (-$0.29) (vs. est. -$0.23), revenue up 12% YoY to $244.3M (vs. est. $242.5M). Q1 revenue guidance: $214M-$225M (vs. est. $242.8M), Q1 net loss expected at ($94M-$83M). Q4 adj. EBITDA: $2.9M.
🔸 Rocket Companies ( $RKT) – Q4 adj. EPS: $0.04 (vs. est. $0.03), total revenue: $1.76B, adj. revenue: $1.2B (high end of guidance). Q1 revenue guidance: $1.17B-$1.325B.
🔸 Acadia Healthcare ( $ACHC) – Q4 adj. EPS: $0.64 (vs. est. $0.71), adj. EBITDA: $153.1M (vs. est. $171.4M), revenue: $774.2M (vs. est. $779M). FY revenue guidance: $3.3B-$3.4B (vs. est. $3.441B), adj. EBITDA: $675M-$725M (vs. est. $747.9M), adj. EPS: $2.50-$2.80 (vs. est. $3.35).
🔸 Iovance Biotherapeutics ( $IOVA) – Q4 EPS loss: (-$0.26) (vs. est. -$0.27), revenue: $73.7M (vs. est. $72.2M). Reaffirms FY25 total product revenue guidance of $450M-$475M. Amtagvi total revenue: $73.7M in Q4, $164.1M in FY24.
🔸 Natera ( $NTRA) – Q4 EPS: (-$0.41) (vs. est. -$0.42), revenue: $476.1M (vs. est. $428.6M). FY revenue guidance: $1.87B-$1.95B (vs. est. $1.819B), gross margin: 60%-64%.
🔸 Pacira BioSciences ( $PCRX) – Q4 EPS: $0.96 (vs. est. $0.83), revenue: $187.3M (vs. est. $185.4M). FY25 revenue guidance: $725M-$765M (vs. est. $747.6M), gross margin: 76%-78%, R&D expense: $90M-$105M, SG&A expense: $290M-$320M.
🔸 Progyny ( $PGNY) – Q4 adj. EPS: $0.42 (vs. est. $0.10), adj. EBITDA: $47.5M (vs. est. $41.8M), revenue: $298.4M (vs. est. $276.7M). Q1 revenue guidance: $300M-$318M (vs. est. $280.3M), FY revenue: $1.175B-$1.225B (vs. est. $1.159B), adj. EPS: $1.52-$1.62 (vs. est. $0.60).
🔸 RadNet ( $RDNT) – Q4 adj. EPS: $0.22 (vs. est. $0.20), adj. EBITDA: $75M (vs. est. $74.8M), revenue: $477.1M (vs. est. $461.8M). FY revenue guidance: $1.825B-$1.875B (vs. est. $1.979B), adj. EBITDA: $265M-$273M (vs. est. $309.3M), FCF: $70M-$80M.
🔸 Solventum ( $SOLV) – Q4 adj. EPS: $1.41 (vs. est. $1.32), revenue: $2.07B (vs. est. $2.05B). FY adj. EPS guidance: $5.45-$5.65 (vs. est. $5.49).
🔸 TransMedics Group ( $TMDX) – Q4 EPS: $0.19 (vs. est. $0.16), revenue: $121.6M (vs. est. $110.3M), gross margin: 59%. FY revenue guidance: $530M-$552M (vs. est. $528.6M).
🔸 Boeing ( $BA) & Safran – Assessing impact of a fire at Pennsylvania's SPS Technologies factory, seeking alternative suppliers. GE Aerospace (GE) taking steps to minimize disruption.
🔸 Archer Aviation ( $ACHR) – Q4 adj. EBITDA: -$94.8M, operating expenses up 16% YoY to $124.2M, net loss: -$198.1M (+82% YoY). Q1 adj. EBITDA loss guidance: -$95M to -$110M.
🔸 MasTec ( $MTZ) – Q4 EPS: $1.44 (vs. est. $1.26), revenue: $3.4B (+3.8% YoY, vs. est. $3.32B). Q1 EPS guidance: $0.34 (vs. est. $0.39). 2025 outlook: revenue $13.45B (+9% YoY), GAAP net income: $327M-$366M, adj. EBITDA: $1.10B-$1.15B.
🔸 Mosaic ( $MOS) – Q4 adj. EPS: $0.45 (vs. est. $0.57), revenue: $2.8B (vs. est. $2.92B). Missed estimates due to lower potash prices and sales. Q4 potash sales volume: 2.2M tonnes (-15% YoY), avg. price: $199/tonne (-18%). Potash revenue: $600M (-25%), adj. core profit: $95M (-24%).
🔸 Rocket Lab USA ( $RKLB) – Q4 adj. EBITDA: -$23.2M (vs. est. -$29.1M), revenue: $84M (vs. est. $130.6M). Q1 revenue guidance: $117M-$123M (vs. est. $135.7M), adj. gross margin: 30%-32%, adj. EBITDA: -$35M.
🔸 Autodesk ( $ADSK) – Q4 adj. EPS: $2.29 (vs. est. $2.14), revenue: $1.6B (vs. est. $1.632B), adj. EBIT margin: 37%. Q1 guidance: revenue $1.6B-$1.61B (vs. est. $1.598B), EPS $2.14-$2.17 (vs. est. $2.08). FY guidance: revenue $6.895B-$6.965B, adj. op margin 36%-37%, EPS $9.34-$9.67 (vs. est. $9.24).
🔸 Dell ( $DELL) – Q4 adj. EPS: $2.68 (vs. est. $2.52), revenue: $23.9B (vs. est. $24.57B). Q1 guidance: EPS $1.65 (vs. est. $1.83), revenue $22.5B-$23.5B (vs. est. $23.72B). FY26 midpoint in line with consensus. Announced $10B stock buyback and 18% dividend increase to $2.10.
🔸 DoubleVerify ( $DV) – Q4 adj. EBITDA: $73.8M (vs. est. $76.48M), revenue: $190.6M (vs. est. $196.9M). Q1 guidance: revenue $151M-$155M (vs. est. $157.5M). FY revenue expected to grow ~10% (vs. est. 12.59%).
🔸 Duolingo ( $DUOL) – Q4 EPS: $0.28 (vs. est. $0.48), revenue: $209.6M (vs. est. $205.4M), paid subs: 9.5M, DAU: 40.5M, MAU: 116.7M. Q1 guidance: revenue $220.5M-$223.5M (vs. est. $221.07M). FY guidance: revenue $962.5M-$978.5M (vs. est. $965.88M).
🔸 Elastic ( $ESTC) – Shares surged on strong Q3 results: adj. EPS $0.63 (vs. est. $0.47), adj. op income $64M (vs. est. $55.4M), revenue $382.5M (vs. est. $368.7M). Q4 guidance: revenue $379M-$381M (vs. est. $374.2M), adj. op margin ~13.5%, adj. EPS $0.36-$0.37 (vs. est. $0.31).
🔸 HP ( $HPQ) – Q1 adj. EPS: $0.74 (in line), revenue: $13.5B (vs. est. $13.36B). Growth driven by strong personal systems segment: revenue up 5% to $9.2B, commercial PC revenue up 10%. Q2 guidance: EPS $0.75-$0.85 (vs. est. $0.86). FY EPS: $3.45-$3.75 (vs. est. $3.59).
🔸 iHeartMedia ( $IHRT) – Q4 adj. EBITDA: $246M (vs. est. $291.3M), revenue: $1.118B (vs. est. $1.166B). Q1 guidance: adj. EBITDA $100M-$110M (vs. est. $120.25M).
🔸 NetApp ( $NTAP) – Q3 EPS: $1.91 (in line), revenue: $1.64B (vs. est. $1.7B). Q4 guidance below midpoint. FY25 guidance: EPS $7.17-$7.27 (vs. est. $7.33), revenue $6.49B-$6.64B (vs. est. $6.67B).
🔸 SoundHound AI ( $SOUN) – Q4 adj. EPS: -$0.05 (vs. est. -$0.10), revenue: $34.5M (vs. est. $33.69M). FY guidance: revenue $157M-$177M (vs. est. $165.26M).
#Upgrades - Nov 12, 2024
• $ARGX: Wolfe Research Upgrades to Outperform from Peerperform
• $ARGX: Wolfe Research Upgrades to Outperform from Peerperform - PT $697
• $BKE: UBS Upgrades to Neutral from Sell - PT $46 (from $31)
• $BMY: Leerink Partners Upgrades to Outperform from Market Perform - PT $73 (from $55)
• $CHRW: Citi Upgrades to Buy from Neutral - PT $125 (from $117)
• $CNI: Citi Upgrades to Buy from Neutral - PT $130 (from $126)
• $CRI: Citi Upgrades to Neutral from Sell - PT $50
• $IFF: Morgan Stanley Upgrades to Overweight from Equalweight - PT $110 (from $111)
• $IHRT: BofA Securities Upgrades to Neutral from Underperform - PT $3 (from $1)
• $S: Deutsche Bank Upgrades to Buy from Hold - PT $32 (from $25)
• $SABK: Janney Upgrades to Buy from Neutral
• $TWLO: Wells Fargo Upgrades to Overweight from Equal Weight - PT $120 (from $80)
• $VIK: Morgan Stanley Upgrades to Overweight from Equalweight - PT $49 (from $37)